Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

589
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
589
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

849
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
849
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.0K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.0K
Inflammation01:38

Inflammation

64.6K
Overview
64.6K
Lipid Absorption01:24

Lipid Absorption

3.6K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of a home-based exercise and physical activity intervention after inpatient rehabilitation on real-world mobility in older adults with cognitive impairment: a secondary analysis of a randomised controlled trial.

Age and ageing·2026
Same author

Determinants of out-of-home activity in older adults with cognitive impairment following inpatient rehabilitation: A secondary cross-sectional analysis of a randomised controlled trial using location-based and accelerometer-derived measures.

Clinical rehabilitation·2026
Same author

Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms.

Nature communications·2026
Same author

Home-Based Intervention to Prevent Functional Decline in (Pre)frail Older Adults: The PromeTheus Randomized Controlled Trial.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Subcutaneous Defibrillation and Coronary Sinus Pacing After Ventricular Fibrillation With Right Ventricular Metastasis.

JACC. Case reports·2026
Same author

Functional characterization of 42 CK2α de novo variants associated with Okur-Chung neurodevelopmental syndrome.

The FEBS journal·2026
Same journal

A new era in carotid prevention - critical appraisal of the CREST-2 results.

VASA. Zeitschrift fur Gefasskrankheiten·2026
Same journal

Management of venous thromboembolism in France - a nationwide clinical practice survey among vascular medicine specialists.

VASA. Zeitschrift fur Gefasskrankheiten·2026
Same journal

Endovascular salvage of distal infrainguinal bypass anastomotic stenosis following thrombectomy using a heparin-bonded covered stent.

VASA. Zeitschrift fur Gefasskrankheiten·2026
Same journal

Optimal ablation length for effective treatment of great saphenous vein insufficiency.

VASA. Zeitschrift fur Gefasskrankheiten·2026
Same journal

Long-term outcomes of covered versus bare metal stents in the reconstruction of the aortic bifurcation.

VASA. Zeitschrift fur Gefasskrankheiten·2026
Same journal

Early discharge and home treatment after acute pulmonary embolism.

VASA. Zeitschrift fur Gefasskrankheiten·2026
See all related articles

Related Experiment Video

Updated: Apr 4, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.7K

Moving beyond the "LDL hypothesis".

Christian Werner1, Ulrich Laufs

  • 11 Clinic for Internal Medicine III - Cardiology, Angiology and Internal Intensive Medicine, Saarland University Hospital, Homburg/Saar, Germany.

VASA. Zeitschrift Fur Gefasskrankheiten
|August 29, 2015
PubMed
Summary
This summary is machine-generated.

The "LDL hypothesis" linking low-density lipoprotein cholesterol (LDL-C) to cardiovascular events is now proven. Genetic and clinical data confirm LDL-C causality, supporting its replacement with "LDL causality" in scientific discourse.

Keywords:
AtherosclerosisHMG CoA reductase inhibitorscardiovascular risk reductionezetimibelow-density lipoprotein cholesterolstatins

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.9K

Related Experiment Videos

Last Updated: Apr 4, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.7K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.9K

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Pharmacology

Background:

  • The association between low-density lipoprotein cholesterol (LDL-C) and cardiovascular (CV) events is often termed the "LDL hypothesis."
  • Existing evidence from epidemiology and mechanistic studies suggested a link, but definitive proof was sought.

Purpose of the Study:

  • To evaluate the causal relationship between serum LDL-C and CV events.
  • To determine if the "LDL hypothesis" is sufficiently proven to warrant a name change to "LDL causality."

Main Methods:

  • Analysis of recent genetic studies demonstrating a causal link between LDL-C and CV events.
  • Review of mechanistic molecular studies and epidemiological data.
  • Examination of new randomized clinical trial data on LDL-C lowering therapies (statins and ezetimibe).

Main Results:

  • Genetic studies provide strong evidence for a causal relationship between serum LDL-C and CV events.
  • Clinical trials confirm that reducing LDL-C levels with statins and ezetimibe effectively reduces CV events.
  • The accumulated data strongly support the causal role of LDL-C in cardiovascular disease.

Conclusions:

  • The "LDL hypothesis" is considered proven based on current scientific evidence.
  • The term "LDL causality" is proposed as a more accurate descriptor than "LDL hypothesis."
  • This shift in terminology reflects the established causal link between LDL-C and cardiovascular events.